Ali Khademhosseini
Ali Khademhosseini is a prominent Iranian-Canadian bioengineer and scientist known for his significant contributions to the fields of tissue engineering, biomaterials, and regenerative medicine. He is a Professor at the University of California, Los Angeles (UCLA) and the Director of the Center for Minimally Invasive Therapeutics (C-MIT).
Early Life and Education
Ali Khademhosseini was born in Tehran, Iran. He moved to Canada at a young age and pursued his higher education there. He received his B.Sc. in Chemical Engineering from the University of Toronto. He then went on to earn his Ph.D. in Bioengineering from the Massachusetts Institute of Technology (MIT) under the supervision of Robert Langer.
Career
After completing his Ph.D., Khademhosseini joined the faculty at Harvard Medical School and the Harvard-MIT Division of Health Sciences and Technology. He later moved to UCLA, where he has continued his groundbreaking research.
Research
Khademhosseini's research focuses on developing innovative biomaterials and microfabrication techniques for tissue engineering and regenerative medicine. His work has led to advancements in the creation of hydrogels, microscale technologies, and organ-on-a-chip systems. These technologies have potential applications in drug delivery, disease modeling, and the development of artificial organs.
Publications and Patents
Khademhosseini has authored over 500 peer-reviewed articles and holds numerous patents in the field of bioengineering. His work is highly cited, and he is considered one of the leading researchers in his field.
Awards and Honors
Throughout his career, Khademhosseini has received numerous awards and honors, including the Pioneers of Miniaturization Prize, the Clemson Award from the Society For Biomaterials, and the Young Investigator Award from the Controlled Release Society.
Personal Life
Khademhosseini is married and has children. He is known for his dedication to mentoring young scientists and fostering interdisciplinary collaboration.
See Also
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD